Organizational structure and processes in pediatric heart transplantation: A survey of practices

Pediatric Transplantation

Volumn 16, Issue 3, 2012, Pages 257-264

  Stendahl, Gail ^a   Bobay, Kathleen ^b   Berger, Stuart ^c   Zangwill, Steven ^c  

^a Children's Hospital of Wisconsin ^*  (United States)

^b MARQUETTE UNIVERSITY   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

heart transplantation; pediatric; survey of practices

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; CYTOKINE RECEPTOR ANTAGONIST; CYTOMEGALOVIRUS ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GANCICLOVIR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID; NYSTATIN; PREDNISONE; RAPAMYCIN; STEROID; SULFAMETHOXAZOLE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIMETHOPRIM; VALGANCICLOVIR;

BACTERIAL INFECTION; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC PATIENT; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; DATA BASE; DRUG SENSITIZATION; GENETIC VARIABILITY; GRAFT RECIPIENT; HEALTH PROGRAM; HEALTH SURVEY; HEART TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; KIDNEY DISEASE; MEDICAL PRACTICE; MYCOSIS; ORGANIZATIONAL STRUCTURE; PATIENT CARE; PATIENT COMPLIANCE; PNEUMOCYSTOSIS; REVIEW; TREATMENT RESPONSE;

ADOLESCENT; CARDIOLOGY; CHILD; DATABASES, FACTUAL; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART TRANSPLANTATION; HUMANS; INFECTION; INTERNET; MODELS, ORGANIZATIONAL; PEDIATRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84859732095     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01636.x     Document Type: Review

References (33)

1. Webber SA,. The current state of, and future prospects for, cardiac transplantation in children. Cardiol Young 2003: 13: 64-83.
2. Kirk R, Edwards LB, Aurora P, et al., Registry of the International Society for Heart and Lung Transplantation: Eleventh official pediatric heart transplantation report-2008. J Heart Lung Transplant 2008: 27: 970-977.
3. Davies RR, Russo MJ, Mital S, et al., Predicting survival among high-risk pediatric cardiac transplant recipients: An analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2008: 135: 147, 155.e2.
4. Canter C, Naftel D, Caldwell R, et al., Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. Circulation 1997: 96: 227-231.
5. Morales DL, Dreyer WJ, Denfield SW, et al., Over two decades of pediatric heart transplantation: How has survival changed? J Thorac Cardiovasc Surg 2007: 133: 632-639.
6. Kirk R, Edwards LB, Kucheryavaya AY, et al., Registry of the International Society for Heart and Lung Transplantation: Thirteenth official pediatric heart transplantation report-2010. J Heart Lung Transplant 2010: 29: 1119-1128.
7. Costanzo MR, Dipchand A, Starling R, et al., The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010: 29: 914-956.
8. Beauchesne LM, Therrien J, Alvarez N, et al., Structure and process measures of quality of care in adult congenital heart disease patients: A Pan-Canadian study. IJCA 2010: article in press.
9. Girouard S, Levine G, Goodrich K, et al., Infection control programs at children's hospitals: A description of structures and processes. Am J Infect Control 2001: 29: 145-151.
10. Donabedian A,. The quality of care: How can it be assessed? JAMA 1998: 260: 1743-1748.
11. Liebel D, Friedman B, Watson N, Powers B,. Review of nurse home visiting interventions for community-dwelling older persons with existing disability. Med Care Res Rev 2009: 66: 119-146.
12. Pollock SM, Den Hollander N, Kantor PF, et al., Heart transplantation in pediatric HLA-sensitized patients. Circulation 2006: 114: 359-360.
13. Holt DB, Lublin DM, Phelan DL, et al., Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant 2007: 26: 876-882.
14. Green H, Paul M, Vidal L, Leibovici L,. Prophylaxis pneumocytis pneumonia in immunocompromised non-HIV-infected patients: Systematic review and meta-analysis of randomized control trials. Mayo Clin Proc 2007: 82: 1052-1059.
15. Raichlin E, Villarraga H, Chandrasekaran K, Clavell A,. Cardiac allograft remodeling after heart transplant is associated with increased graft vasculopathy and mortality. Am J Transplant 2009: 9: 132-139.
16. Zangwill S, Ellis T, Stendahl G, Zahn A, Berger S, Tweddell J,. Practical application of the virtual crossmatch. Pediatr Transplant 2007: 11: 650-654.
17. U nited N etwork for O rgan S haring. Waitlist Data. Available at: (accessed January 14, 2010).
18. Gupta S, Mitchell JD, Markham DW, et al., High incidence of cytomegalovirus disease in donor positive/recipient negative heart transplant recipients shortly after completion of 3 months of valganciclovir. J Heart Lung Transplant 2008: 27: 536-539.
19. Rossano JW, Denfield SW, Kim JJ, Price JF,. Assessment of the cylex ImmuKnow cell function assay in pediatric heart transplant patients. J Heart Lung Transplant 2009: 28: 26-31.
20. Reding R, Webber SA, Fine R,. Getting rid of steroids in pediatric solid-organ transplantation? Pediatr Transplant 2004: 8: 526-530.
21. Simmonds J, Dewar C, Dawkins H, Burch M, Fenton M,. Tacrolimus in pediatric heart transplantation: Ameliorated side effects in the steroids-free, statin era. Clin Transplant 2009: 23: 415-419.
22. Singh T, Faber C, Blume E, Worley S,. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients. J Heart Lung Transplant 2010: 29: 517-522.
23. Mahle WT,. Cardiac retransplantation in children. Pediatr Transplant 2008: 12: 274-280.
24. Pahl E,. Statins in the prevention of transplant coronary artery disease: In pediatric heart recipients. Pediatr Transplant 2007: 11: 459-460.
25. Lobach NE, Pollock-BarZiv SM, West LJ, Dipchand AI,. Sirolimus immunosuppression in pediatric heart transplant recipients: A single-center experience. J Heart Lung Transplant 2005: 24: 184-189.
26. Ubilla M, Mastrobuoni S, Cordero A, Castama H,. Impact on renal function of the use of sirolimus in cardiac transplantation. Transplant Proc 2007: 39: 2401-2402.
27. Levi DS, DeConde AS, Fishbein MC, Burch C,. The yield of surveillance endomyocardial biopsies as a screen for cellular rejection in pediatric heart transplant. Pediatr Transplant 2004: 8: 22-28.
28. Hsu DT,. Can non-invasive methodology predict rejection and either dictate or obviate the need for an endomyocardial biopsy in pediatric heart transplant recipients? Pediatr Transplant 2005: 9: 697-699.
29. McDonagh J, Kaufman M,. Transition from pediatric to adult care after solid organ transplantation. Curr Opin Organ Transplant 2009: 14: 526-532.
30. Lawrence K, Stilley C, Olshansky E, Bender A,. Further exploration: Maturity and adherence in adolescent and young adult heart transplant recipients. Prog Transplant 2008: 18: 50-54.
31. Irving CA, Webber SA,. Immunosuppression therapy for pediatric heart transplantation. Curr Treat Options Cardiovasc Med 2010: 12: 489-502.
32. McAllister S, Buckner E, White-Williams C,. Medication adherence after heart transplantation: Adolescents and their issues. Prog Transplant 2007: 16: 317-323.
33. Aujoulat I, Deccache A, Charles A, et al., Non-adherence in adolescent transplant recipients: The role of uncertainty in health care providers. Pediatr Transplant 2011: 15: 148-156.